Business / Finance

RSS

Omega Protein fourth quarter revenues increase 46% to $62.8M

Omega Protein Corporation, a nutritional ingredient company and the nation's leading vertically integrated producer of omega-3 fish oil and specialty fish meal products, today reported financial results for the fourth quarter and full year ended December 31, 2011.

8 Mar 2012

Cantel second quarter net income increases 28% to $7,294,000

CANTEL MEDICAL CORP. reported a 28% increase in net income to a record $7,294,000, or $0.27 per diluted share, on a 20% increase in sales to a record $97,297,000 for the second quarter ended January 31, 2012.

8 Mar 2012

Amylin prices public offering of 13,000,000 shares of common stock

Amylin Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock.

8 Mar 2012

Columbia Labs fourth quarter total net revenues decrease to $6.4M

Columbia Laboratories, Inc. today reported financial results for the three- and twelve-month periods ended December 31, 2011.

8 Mar 2012

Bellicum raises $20M in Series B financing

Bellicum Pharmaceuticals, Inc. today announced that it has raised $20 million in a Series B financing. The funding will be used to advance its lead CaspaCIDe and DeCIDe programs through Phase 2 clinical development.

8 Mar 2012

Heborium first quarter sales increase 23%

Herborium Group, Inc., is pleased to announce today that the Company' Internet sales for first quarter of 2012 grew 23% in comparison to the same quarter of 2011.

8 Mar 2012

Medtech acquires Camelot Healthcare Training Institute

Camelot Healthcare Training Institute, a post-secondary nursing and allied health care education provider in Central Florida, has been acquired by Medtech College. Camelot now joins the Medtech family of schools and will become Medtech College once appropriate state approvals have been obtained.

8 Mar 2012

Zalicus fourth quarter revenue decreases to $8.2 million

Zalicus Inc. today reported financial results for the fourth quarter and year ended December 31, 2011.

8 Mar 2012

Celldex fourth quarter net loss increases to $12.7 million

Celldex Therapeutics, Inc. today reported financial results for the fourth quarter and the year ended December 31, 2011.

8 Mar 2012

Transgenomic fourth quarter total revenue increases 68% to $8.6M

Transgenomic, Inc. today reported financial results for the year ended December 31, 2011 and provided a business update.

7 Mar 2012

Nuance enters definitive agreement to acquire Transcend

Nuance Communications, Inc. and Transcend Services, Inc. today announced a definitive agreement for Nuance to acquire Transcend, a leading provider of medical transcription and speech editing services, for approximately $300 million, net, in cash.

7 Mar 2012

CTI fourth quarter net loss decreases to $17.9 million

Cell Therapeutics, Inc. today reported financial results and recent accomplishments for the fourth quarter and year ended December 31, 2011.

7 Mar 2012

Modern Mobility Aids returns 90M shares of MDRM

Modern Mobility Aids, Inc., headquartered in Nevada, USA, announces that its Chairman and CEO, Mohamed Karatella, today has returned 90 million shares of MDRM from his personal holdings back into the Company's treasury and in doing so has reduced his position in the Company from 130 million to 40 million shares.

7 Mar 2012

Tonix receives net proceeds of $2.0M in private placement offering

Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome ("FM") and post-traumatic stress disorder, has received net proceeds of approximately $2.0 million in a private placement offering to institutional and accredited investors.

6 Mar 2012

Medidata net revenues increase 11% to $184.5M for full year 2011

Medidata Solutions, a leading global provider of SaaS clinical technology solutions that enhance the efficiency of clinical development, today announced its financial results for the fourth quarter and full year 2011, and provided detailed financial guidance for the first quarter and full year 2012.

6 Mar 2012

Community Health Systems subsidiary merges with Diagnostic Clinic of Longview

Community Health Systems, Inc. announced today that a subsidiary of the Company has merged operations with Diagnostic Clinic of Longview, P.A., a large multi-specialty clinic serving residents of Longview, Texas, and surrounding East Texas communities.

6 Mar 2012

Carl Zeiss Meditec wins NFSB award for excellence in customer service

Medical technology provider Carl Zeiss Meditec has been awarded the NorthFace ScoreBoard (NFSB) Award(SM) from the Omega Management Group Corp. in recognition of achieving excellence in customer service and support in 2011. This is the ninth straight year that the company has been honored with this award.

6 Mar 2012

EntreMed plans to establish drug development office in China

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has initiated plans to establish an office in China to facilitate the Company's drug development and clinical trials in that country.

6 Mar 2012

Cross Country Healthcare fourth quarter revenue increases 10% to $124.7M

Cross Country Healthcare, Inc. today reported revenue of $124.7 million in the fourth quarter ended December 31, 2011, a 10% increase from revenue of $113.7 million in the prior year quarter and a 5% decrease sequentially from the third quarter of 2011.

6 Mar 2012

PSI 2011 revenue up 25%

PSI, a full-service global CRO known for on-time patient enrollment and project delivery, announces 2011 results reporting record growth in new client wins and 25% year-over-year revenue increase.

6 Mar 2012